BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17616672)

  • 1. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.
    Valenzuela HF; Pace KE; Cabrera PV; White R; Porvari K; Kaija H; Vihko P; Baum LG
    Cancer Res; 2007 Jul; 67(13):6155-62. PubMed ID: 17616672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation.
    Roberts AA; Amano M; Felten C; Galvan M; Sulur G; Pinter-Brown L; Dobbeling U; Burg G; Said J; Baum LG
    Mod Pathol; 2003 Jun; 16(6):543-51. PubMed ID: 12808059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.
    André S; Sanchez-Ruderisch H; Nakagawa H; Buchholz M; Kopitz J; Forberich P; Kemmner W; Böck C; Deguchi K; Detjen KM; Wiedenmann B; von Knebel Doeberitz M; Gress TM; Nishimura S; Rosewicz S; Gabius HJ
    FEBS J; 2007 Jul; 274(13):3233-56. PubMed ID: 17535296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression.
    Hagisawa S; Ohyama C; Takahashi T; Endoh M; Moriya T; Nakayama J; Arai Y; Fukuda M
    Glycobiology; 2005 Oct; 15(10):1016-24. PubMed ID: 15932919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype.
    Ellerhorst J; Nguyen T; Cooper DN; Lotan D; Lotan R
    Int J Oncol; 1999 Feb; 14(2):217-24. PubMed ID: 9917495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of PSA secretion and survival signaling by calcium-independent phopholipase A(2)beta in prostate cancer cells.
    Nicotera TM; Schuster DP; Bourhim M; Chadha K; Klaich G; Corral DA
    Prostate; 2009 Sep; 69(12):1270-80. PubMed ID: 19475654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
    Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R
    Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer.
    Fukumori T; Oka N; Takenaka Y; Nangia-Makker P; Elsamman E; Kasai T; Shono M; Kanayama HO; Ellerhorst J; Lotan R; Raz A
    Cancer Res; 2006 Mar; 66(6):3114-9. PubMed ID: 16540661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of prostate-specific antigen expression by the junctional adhesion molecule A.
    Wang Q; Zheng JY; Kreth J; Yan X; Kamata M; Campbell RA; Xie Y; Chiu R; Berenson JR; Shi W; Chen IS; Pang S
    Urology; 2009 May; 73(5):1119-25. PubMed ID: 18602143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface N-glycosylation and sialylation regulate galectin-3-induced apoptosis in human diffuse large B cell lymphoma.
    Suzuki O; Abe M
    Oncol Rep; 2008 Mar; 19(3):743-8. PubMed ID: 18288410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.
    Peracaula R; Tabarés G; Royle L; Harvey DJ; Dwek RA; Rudd PM; de Llorens R
    Glycobiology; 2003 Jun; 13(6):457-70. PubMed ID: 12626390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death.
    Toscano MA; Bianco GA; Ilarregui JM; Croci DO; Correale J; Hernandez JD; Zwirner NW; Poirier F; Riley EM; Baum LG; Rabinovich GA
    Nat Immunol; 2007 Aug; 8(8):825-34. PubMed ID: 17589510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients.
    van den Brûle FA; Waltregny D; Castronovo V
    J Pathol; 2001 Jan; 193(1):80-7. PubMed ID: 11169519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.
    Myrthue A; Rademacher BL; Pittsenbarger J; Kutyba-Brooks B; Gantner M; Qian DZ; Beer TM
    Clin Cancer Res; 2008 Jun; 14(11):3562-70. PubMed ID: 18519790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin induces apoptosis in human prostate cancer cell LNCaP.
    Yu CX; Zhang XQ; Kang LD; Zhang PJ; Chen WW; Liu WW; Liu QW; Zhang JY
    Asian J Androl; 2008 Jul; 10(4):625-34. PubMed ID: 18478162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
    Peternac D; Klima I; Cecchini MG; Schwaninger R; Studer UE; Thalmann GN
    Prostate; 2008 Sep; 68(12):1307-18. PubMed ID: 18512728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rap2 regulates androgen sensitivity in human prostate cancer cells.
    Bigler D; Gioeli D; Conaway MR; Weber MJ; Theodorescu D
    Prostate; 2007 Oct; 67(14):1590-9. PubMed ID: 17918750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.
    Fry SA; Van den Steen PE; Royle L; Wormald MR; Leathem AJ; Opdenakker G; McDonnell JM; Dwek RA; Rudd PM
    Biochemistry; 2006 Dec; 45(51):15249-58. PubMed ID: 17176047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients.
    Holmes EH; Greene TG; Tino WT; Boynton AL; Aldape HC; Misrock SL; Murphy GP
    Prostate Suppl; 1996; 7():25-9. PubMed ID: 8950359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
    Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.